Bronwyn MacInnis is Director of Pathogen Genomic Surveillance and an Institute Scientist in the Infectious Disease and Microbiome Program at the Broad Institute of MIT and Harvard. She also co-leads the Broad’s multidisciplinary Global Health Initiative and is a visiting scientist at the Harvard T.H. Chan School of Public Health.

Dr. MacInnis works to leverage the resources of the Broad to drive innovative infectious disease genomics research, and to translate this into practical applications for global health. Her primary focus is on developing and implementing genomic surveillance approaches for malaria and viral pathogens, and building local capacity to integrate these into routine public health practice. Currently Dr MacInnis is co-leading the Broad’s large scale COVID-19 viral sequencing and genomic surveillance effort, working closely with the Massachusetts and other State Departments of Public Health and the US Centers for Disease Control to monitor variants of concern and to track the evolution and spread of SARS-CoV-2 in New England. Her work in West Africa focuses on malaria genomic surveillance, outbreak prevention and response, and genomics capacity building. She also serves as a technical advisor to the World Health Organization to develop genomic data use cases and data sharing guidelines for their global pandemic preparedness strategy. Prior to joining the Broad Institute, MacInnis was a senior scientific program manager at the Wellcome Sanger Institute in the UK, where she co-led the Malaria Genomic Epidemiology Network (MalariaGEN), a global data sharing community aimed at translating genome science into tools for malaria control and elimination.

MacInnis completed her Ph.D. at the University of Alberta in Canada, and was a Human Frontiers in Science Program Postdoctoral Fellow at Stanford University.